Tranexamic Acid vs Hydroquinone for Melasma: Complete Comparison Guide | Korean Plastic Surgery

Tranexamic acid reduces melanocyte activation by blocking plasmin and UV-induced inflammatory pathways, while hydroquinone inhibits tyrosinase to reduce melanin production directly. Both are evidence-supported for melasma but differ in mechanism, side-effect profile, and how they are deployed in Korean dermatology practice. This guide compares the two across mechanism, efficacy data, side effects, route of administration (oral vs topical), pregnancy considerations, cost in Korea (2026), and a clinical decision framework for international patients planning melasma treatment.

Mechanism of Action: How Each Drug Works

Tranexamic acid (TXA) is a synthetic lysine derivative that competitively inhibits plasminogen activation. In melasma, plasmin activity drives prostaglandin and arachidonic acid pathways that stimulate melanocytes. By blocking plasmin, TXA reduces UV- and inflammation-triggered melanin production at the molecular signaling level. Hydroquinone (HQ) acts further downstream — it inhibits tyrosinase, the rate-limiting enzyme in melanin synthesis, and disrupts melanosome formation in melanocytes. TXA targets the trigger; HQ targets the production line. Korean dermatology practice routinely uses both, often layered.

Efficacy Evidence: What Studies Show

Multiple randomized trials and meta-analyses (PubMed-indexed) report meaningful melasma score reductions for both agents. Oral TXA 250 mg twice daily for 8–12 weeks reduces melasma severity scores (MASI) by approximately 30–50% in published series. Topical HQ 4% (compounded prescription strength) achieves comparable or slightly higher reductions over 12 weeks. Combination protocols — topical HQ plus oral or topical TXA — often outperform monotherapy. Response rates vary by Fitzpatrick skin type and chronicity. Maintenance is essential; both agents require continued sun protection.

Side Effect Profiles Compared

Hydroquinone side effects include skin irritation, contact dermatitis, post-inflammatory hyperpigmentation, and rare exogenous ochronosis with long-term use of high concentrations. Most Korean dermatologists limit HQ use to 12–16 week cycles followed by holidays. Tranexamic acid (oral) side effects include nausea, menstrual irregularity, and a theoretical thrombotic risk; absolute contraindications include personal or family history of thromboembolic events, smoking + estrogen contraceptive use, and pregnancy. Topical TXA has minimal systemic concern. Korean clinics screen patients with a thrombosis questionnaire before prescribing oral TXA.

Oral vs Topical Routes: When to Use Each

Oral TXA suits widespread, recalcitrant melasma when topical agents have plateaued, in patients without thrombotic risk factors. Topical TXA serums (typically 2–5%) suit milder cases or maintenance. Topical HQ remains the most widely prescribed first-line agent in Korean practice for moderate melasma, typically used 4–8 weeks then tapered. Combination protocols (e.g., HQ 4% + tretinoin 0.025% + low-dose corticosteroid as Kligman's formula) are commonly compounded. Korean clinics often individualize routes by chronicity and skin type.

Pregnancy and Breastfeeding Considerations

Hydroquinone is generally avoided in pregnancy and breastfeeding due to systemic absorption concerns. Tranexamic acid is contraindicated in pregnancy for melasma indication. Pregnancy-related melasma (chloasma) often improves spontaneously postpartum; sun protection and gentle topical agents are first-line during pregnancy. International patients planning treatment should disclose pregnancy plans during consultation. Korean clinics adhere to KCD (Korean College of Dermatology) pregnancy advisory practices.

Cost Range in Korea (2026): Treatment and Maintenance

Consultation USD 50–120. Prescription HQ 4% (compounded) USD 30–60 per tube (1–2 month supply). Oral TXA 250 mg × 60 tablets USD 25–45. Topical TXA serum (clinic-grade) USD 60–140. Combination protocols including laser support (e.g., Spectra picosecond toning) range USD 200–450 per session, typically 4–8 sessions. Cosmeceutical maintenance products USD 30–90 monthly. Pricing varies by Gangnam vs other districts. KHIDI medical tourism centers can issue itemized estimates.

Decision Framework: 5 Steps Before Booking

(1) Assess melasma severity and pattern (centrofacial, malar, mandibular). (2) Confirm pregnancy and thrombosis status. (3) Discuss tolerance for daily topical regimen. (4) Review timeline — meaningful improvement requires 8–12 weeks minimum. (5) Plan maintenance and sun protection strategy. Mild-to-moderate cases without thrombotic risk: combination topical HQ + topical TXA. Severe recalcitrant: oral TXA + topical HQ + adjunctive laser. Pregnancy-related: postpone systemic therapy.

Adjunctive Laser and Procedural Considerations

Korean dermatology practice often layers procedural therapy with topical/oral pharmacotherapy. Picosecond laser toning (Spectra, PicoSure, Discovery Pico) is used at low fluence weekly for 4–8 sessions. Aggressive fractional or Q-switched single-pass treatments are generally avoided in melasma because they can worsen post-inflammatory hyperpigmentation. Microneedling with topical TXA (transdermal delivery) has shown promise in recent Korean publications. Adjunctive procedures complement but do not replace systemic and topical foundation therapy.

Frequently Asked Questions

How long until I see melasma improvement?

Meaningful reduction typically requires 8–12 weeks of consistent treatment. Full benefit may take 4–6 months with maintenance.

Can I use hydroquinone long-term?

Long-term continuous high-concentration hydroquinone is discouraged due to ochronosis risk. Korean practice uses 12–16 week cycles with treatment holidays.

Is oral tranexamic acid safe?

Oral TXA is generally safe in screened patients without thrombotic risk factors. Pregnancy, recent surgery, smoking + estrogen contraceptive use, and personal/family clot history are contraindications.

Does sunscreen really matter for melasma?

Sunscreen is the single most important adjunct. Broad-spectrum SPF 50+ with iron oxides (visible light protection) is recommended.

Will melasma return after treatment?

Recurrence is common without maintenance and sun protection. Long-term strategy combines preventive sun protection, periodic procedural sessions, and low-intensity topical maintenance.

If you are planning treatment in Korea, schedule a no-obligation consultation with a board-certified clinic curated by Korean Plastic Surgery to receive an itemized written estimate before committing.